| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 162,492 | 15,864 | | Cost of Revenue | 79,036 | 7,921 | | | Gross Profit | 83,456 | 7,943 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 13,647 | 1,562 | | Non Recurring | 245,587 |
-
| | Others | 50,988 | 5,046 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (226,766) | 1,335 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 66,578 | (6,086) | | Earnings Before Interest And Taxes | (160,188) | (4,751) | | Interest Expense | 13,744 | 13,760 | | Income Before Tax | (173,932) | (18,511) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (173,932) | (18,511) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (173,932) | (18,511) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($173,932) | ($18,511) |
|
1.52% Nasdaq 0.00%
Income Statement
